Tarek Z Bass
Overview
Explore the profile of Tarek Z Bass including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rinne S, Leitao C, Mitran B, Bass T, Andersson K, Tolmachev V, et al.
Sci Rep
. 2019 Jan;
9(1):655.
PMID: 30679757
Radionuclide molecular imaging of human epidermal growth factor receptor 3 (HER3) expression using affibody molecules could be used for patient stratification for HER3-targeted cancer therapeutics. We hypothesized that the properties...
2.
Fenderico N, van Scherpenzeel R, Goldflam M, Proverbio D, Jordens I, Kralj T, et al.
Nat Commun
. 2019 Jan;
10(1):365.
PMID: 30664649
Wnt-induced β-catenin-mediated transcription is a driving force for stem cell self-renewal during adult tissue homeostasis. Enhanced Wnt receptor expression due to mutational inactivation of the ubiquitin ligases RNF43/ZNRF3 recently emerged...
3.
Orlova A, Bass T, Rinne S, Leitao C, Rosestedt M, Atterby C, et al.
Mol Pharm
. 2018 Jul;
15(8):3394-3403.
PMID: 29995421
Human epidermal growth factor receptor type 3 (HER3) is recognized to be involved in resistance to HER-targeting therapies. A number of HER3-targeting monoclonal antibodies are under clinical investigation as potential...
4.
Bass T, Rosestedt M, Mitran B, Frejd F, Lofblom J, Tolmachev V, et al.
Sci Rep
. 2017 Feb;
7:43118.
PMID: 28230065
Overexpression of human epidermal growth factor receptor 3 (HER3) is involved in resistance to several therapies for malignant tumours. Currently, several anti-HER3 monoclonal antibodies are under clinical development. We introduce...